Claudio Nessi - Net Worth and Insider Trading

Claudio Nessi Net Worth

The estimated net worth of Claudio Nessi is at least $778,012 dollars as of 2024-05-22. Claudio Nessi is the Director of X4 Pharmaceuticals Inc and owns about 867,639 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $778,012. Details can be seen in Claudio Nessi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Claudio Nessi has not made any transactions after 2017-11-20 and currently still holds the listed stock(s).

Transaction Summary of Claudio Nessi

To

Claudio Nessi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Claudio Nessi owns 8 companies in total, including Kronos Bio Inc (KRON) , Morphic Holding Inc (MORF) , and Immunic Inc (IMUX) among others .

Click here to see the complete history of Claudio Nessi’s form 4 insider trades.

Insider Ownership Summary of Claudio Nessi

Ticker Comapny Transaction Date Type of Owner
KRON Kronos Bio Inc 2020-10-08 10 percent owner
MORF Morphic Holding Inc 2019-06-26 10 percent owner
IMUX Immunic Inc 2019-04-12 10 percent owner
2018-07-02 10 percent owner
2017-11-20 director & 10 percent owner
2021-10-06 10 percent owner
2021-02-10 10 percent owner
2023-11-02 10 percent owner

Claudio Nessi Latest Holdings Summary

Claudio Nessi currently owns a total of 1 stock. Claudio Nessi owns 867,639 shares of X4 Pharmaceuticals Inc (XFOR) as of November 20, 2017, with a value of $778,012.

Latest Holdings of Claudio Nessi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XFOR X4 Pharmaceuticals Inc 2017-11-20 867,639 0.90 778,012

Holding Weightings of Claudio Nessi


Claudio Nessi Form 4 Trading Tracker

According to the SEC Form 4 filings, Claudio Nessi has made a total of 0 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years. The most-recent trade in X4 Pharmaceuticals Inc is the acquisition of 300,000 shares on November 20, 2017, which cost Claudio Nessi around $3 Million.

Insider Trading History of Claudio Nessi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Claudio Nessi Trading Performance

GuruFocus tracks the stock performance after each of Claudio Nessi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Claudio Nessi is 0.28%. GuruFocus also compares Claudio Nessi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Claudio Nessi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Claudio Nessi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Claudio Nessi

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.97
Relative Return to S&P 500(%) -17.73

Claudio Nessi Ownership Network

Ownership Network List of Claudio Nessi

No Data

Ownership Network Relation of Claudio Nessi


Claudio Nessi Owned Company Details

What does Kronos Bio Inc do?

Who are the key executives at Kronos Bio Inc?

Claudio Nessi is the 10 percent owner of Kronos Bio Inc. Other key executives at Kronos Bio Inc include COO & General Counsel Barbara Kosacz , Chief Scientific Officer Christopher Dinsmore , and Chief Medical Officer & VP Jorge Dimartino .

Kronos Bio Inc (KRON) Insider Trades Summary

Over the past 18 months, Claudio Nessi made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net sale of 69,004 shares made by Jorge Dimartino , a net sale of 39,461 shares made by Christopher Dinsmore , and a net sale of 18,643 shares made by Yasir B. Al-wakeel .

In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 169,293 shares of Kronos Bio Inc (KRON) were sold and 1,731,056 shares were bought by its insiders, resulting in a net purchase of 1,561,763 shares.

Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kronos Bio Inc Insider Transactions

No Available Data

Claudio Nessi Mailing Address

Above is the net worth, insider trading, and ownership report for Claudio Nessi. You might contact Claudio Nessi via mailing address: C/o Neomed, 7 Place Du Molard, 1204 Geneva V8 1204.

Discussions on Claudio Nessi

No discussions yet.